EP0706399A4 - Composition et procede destines a eliminer les sels biliaires - Google Patents

Composition et procede destines a eliminer les sels biliaires

Info

Publication number
EP0706399A4
EP0706399A4 EP94919283A EP94919283A EP0706399A4 EP 0706399 A4 EP0706399 A4 EP 0706399A4 EP 94919283 A EP94919283 A EP 94919283A EP 94919283 A EP94919283 A EP 94919283A EP 0706399 A4 EP0706399 A4 EP 0706399A4
Authority
EP
European Patent Office
Prior art keywords
compositions
bile salts
removing bile
salts
bile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94919283A
Other languages
German (de)
English (en)
Other versions
EP0706399A1 (fr
Inventor
W Harry Mandeville Iii
Stephen Randall Holmes-Farley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geltex Pharmaceuticals Inc
Original Assignee
Geltex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltex Pharmaceuticals Inc filed Critical Geltex Pharmaceuticals Inc
Publication of EP0706399A1 publication Critical patent/EP0706399A1/fr
Publication of EP0706399A4 publication Critical patent/EP0706399A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10—Esters
    • C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52—Amides or imides
    • C08F220/54—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/60—Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
EP94919283A 1993-06-02 1994-05-27 Composition et procede destines a eliminer les sels biliaires Withdrawn EP0706399A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7156493A 1993-06-02 1993-06-02
US71564 1993-06-02
PCT/US1994/006042 WO1994027620A1 (fr) 1993-06-02 1994-05-27 Composition et procede destines a eliminer les sels biliaires

Publications (2)

Publication Number Publication Date
EP0706399A1 EP0706399A1 (fr) 1996-04-17
EP0706399A4 true EP0706399A4 (fr) 1998-08-12

Family

ID=22102137

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94919283A Withdrawn EP0706399A4 (fr) 1993-06-02 1994-05-27 Composition et procede destines a eliminer les sels biliaires

Country Status (4)

Country Link
EP (1) EP0706399A4 (fr)
JP (1) JPH09500368A (fr)
AU (1) AU7047994A (fr)
WO (1) WO1994027620A1 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5487888A (en) 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US6129910A (en) * 1993-06-02 2000-10-10 Geltex Pharmaceuticals, Inc. Water-insoluble noncrosslinked bile acid sequestrants
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5703188A (en) * 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5929184A (en) * 1993-06-02 1999-07-27 Geltex Pharmaceuticals, Inc. Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5624963A (en) * 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5900475A (en) * 1994-06-10 1999-05-04 Geltex Pharmaceuticals, Inc. Hydrophobic sequestrant for cholesterol depletion
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
FR2757866B1 (fr) 1996-12-30 2004-12-17 Catalyse Polymeres comportant des groupes ammoniums quaternaires, leur utilisation pour la fabrication d'un materiau a propretes antibacteriennes et leurs procedes de preparation
US6203785B1 (en) 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
US5925379A (en) * 1997-03-27 1999-07-20 Geltex Pharmaceuticals, Inc. Interpenetrating polymer networks for sequestration of bile acids
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US6190649B1 (en) 1999-04-23 2001-02-20 Geltex Pharmaceuticals, Inc. Polyether-based bile acid sequestrants
IL147361A0 (en) * 1999-07-14 2002-08-14 Geltex Pharma Inc Fat-binding polymers, optionally combined with lipase inhibitors
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
MXPA03009562A (es) * 2001-04-18 2004-02-12 Genzyme Corp METODO PARA TRATAR EL SiNDROME X CON POLIAMINAS ALIFATICAS.
EP2335709A1 (fr) 2004-03-26 2011-06-22 Mitsubishi Tanabe Pharma Corporation Agent pour améliorer la résistance à l'insuline
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
EP3000460A1 (fr) 2005-09-15 2016-03-30 Genzyme Corporation Formulation en sachet pour des polymères amines
DE102006007564A1 (de) * 2006-02-16 2007-08-30 Röhm Gmbh Nanoskalige superparamagnetische Poly(meth)acrylatpolymere
JP5147695B2 (ja) 2006-06-16 2013-02-20 田辺三菱製薬株式会社 糸球体疾患の予防及び／または治療剤
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
MA41202A (fr) 2014-12-18 2017-10-24 Genzyme Corp Copolymères polydiallymine réticulé pour le traitement du diabète de type 2

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
ES2006782A6 (es) * 1987-07-15 1989-05-16 Garcia Alonso Julio Procedimiento de obrencion de resinas intercambiadoras anionicas de uso humano
EP0373852A2 (fr) * 1988-12-13 1990-06-20 Smith Kline & French Laboratories Limited Composés
JPH059234A (ja) * 1991-06-28 1993-01-19 Chuichi Hirayama 発熱物質吸着体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953406A (en) * 1973-01-26 1976-04-27 California Institute Of Technology Water-insoluble, swellable polyurethanes
JPS57142920A (en) * 1981-03-02 1982-09-03 Mitsubishi Petrochem Co Ltd Cholesterol depressant
WO1983002392A1 (fr) * 1982-01-18 1983-07-21 Kihara, Kunio Medicament abaissant le taux de cholesterol

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
ES2006782A6 (es) * 1987-07-15 1989-05-16 Garcia Alonso Julio Procedimiento de obrencion de resinas intercambiadoras anionicas de uso humano
EP0373852A2 (fr) * 1988-12-13 1990-06-20 Smith Kline & French Laboratories Limited Composés
JPH059234A (ja) * 1991-06-28 1993-01-19 Chuichi Hirayama 発熱物質吸着体

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 114, no. 12, 25 March 1991, Columbus, Ohio, US; abstract no. 109016, XP002065385 *
PATENT ABSTRACTS OF JAPAN vol. 017, no. 274 (C - 1064) 27 May 1993 (1993-05-27) *
See also references of WO9427620A1 *

Also Published As

Publication number Publication date
JPH09500368A (ja) 1997-01-14
EP0706399A1 (fr) 1996-04-17
AU7047994A (en) 1994-12-20
WO1994027620A1 (fr) 1994-12-08

Similar Documents

Publication Publication Date Title
EP0706399A4 (fr) Composition et procede destines a eliminer les sels biliaires
AP9300598A0 (en) Compositions and method for waste treatment
ZA947354B (en) Composition and process for treating metal
HUT65710A (en) Method and composition for disinfecting contact-lenses
EP0448300A3 (en) Method and composition for coiontophoresis
ZA949346B (en) Composition and process for treating metal
ZA944323B (en) Method for treating hypoxia-associated ocular complications
AU665318B2 (en) Process for obtaining diatomite-based filtering agents and corresponding filtering agents
AU7970794A (en) Method for removing scale and stains
AU6950894A (en) Composition and method for inhibiting plant disease
HU9601421D0 (en) Detergent compositions and process for preparing them
ZA939731B (en) Detergent composition and process for producing it
SG43669A1 (en) Composition for cleaning and process for cleaning
AU1245395A (en) Method and machine for cleaning components
EP0796114A4 (fr) Procede permettant d'eviter la formation d'un film biologique, de l'oter et composition correspondante
HU9502003D0 (en) Compositions for treating hypoxia-associated ocular complications
HU216713B (hu) Ciklusos acetálok és eljárás az előállításukra
ZA962636B (en) Compositions and process for treating hemangioma
AU9087591A (en) Composition and method for treating metal
ZA948585B (en) Cleaning methods and compositions for produce
GB9315281D0 (en) Method and composition for facilitating the removal of soil contaminants from solid surfaces
HU9403239D0 (en) Selfsticking tearing stkipe and process for making thereof
GB9420539D0 (en) Process and composition
AU7366591A (en) Method and composition for water treatment
AU6276494A (en) Method for treating colic and constipation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951201

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

R17P Request for examination filed (corrected)

Effective date: 19960130

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20000105

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010903